Literature DB >> 28761193

Intranasal mast cell tumor in the dog: A case series.

Alison Khoo1, Amy Lane1, Ken Wyatt1.   

Abstract

The medical records of 4 dogs with histologically confirmed intranasal mast cell tumors (MCTs) were retrospectively evaluated to determine their biological behavior. Information on signalment, presenting clinical signs, tumor grade, treatment administered, and survival times was obtained from the medical record. All 4 patients had high grade tumors and received chemotherapy. Survival times ranged from 27 to 134 days. All 4 dogs showed signs of local or distant disease progression, suggestive of an aggressive behavior of intranasal MCTs.

Entities:  

Mesh：

Year:  2017        PMID： 28761193      PMCID： PMC5508967     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


  27 in total

1.  Neuroendocrine carcinoma of the nasopharynx in a dog.

Authors:  A K Patnaik; L L Ludwig; R A Erlandson
Journal:  Vet Pathol       Date:  2002-07       Impact factor: 2.221

2.  Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital.

Authors:  D Cohen; J S Reif; R S Brodey; H Keiser
Journal:  Cancer Res       Date:  1974-11       Impact factor: 12.701

3.  Skin neoplasms of dogs in Sydney.

Authors:  T L Rothwell; C R Howlett; D J Middleton; D A Griffiths; B C Duff
Journal:  Aust Vet J       Date:  1987-06       Impact factor: 1.281

4.  Outcomes of dogs with grade 3 mast cell tumors: 43 cases (1997-2007).

Authors:  Carrie Tupper Hume; Matti Kiupel; Lora Rigatti; Frances S Shofer; Katherine A Skorupski; Karin U Sorenmo
Journal:  J Am Anim Hosp Assoc       Date:  2010-12-16       Impact factor: 1.023

5.  Outcome of accelerated radiotherapy alone or accelerated radiotherapy followed by exenteration of the nasal cavity in dogs with intranasal neoplasia: 53 cases (1990-2002).

Authors:  William M Adams; Dale E Bjorling; Jonathan E McAnulty; Eric M Green; Lisa J Forrest; David M Vail
Journal:  J Am Vet Med Assoc       Date:  2005-09-15       Impact factor: 1.936

6.  Radiation therapy for incompletely excised grade II canine mast cell tumors.

Authors:  Valerie Jasmine Poirier; William M Adams; Lisa J Forrest; Eric M Green; Richard R Dubielzig; David M Vail
Journal:  J Am Anim Hosp Assoc       Date:  2006 Nov-Dec       Impact factor: 1.023

7.  Biological behavior of oral and perioral mast cell tumors in dogs: 44 cases (1996-2006).

Authors:  Lorin A Hillman; Laura D Garrett; Louis-Philippe de Lorimier; Sarah C Charney; Luke B Borst; Timothy M Fan
Journal:  J Am Vet Med Assoc       Date:  2010-10-15       Impact factor: 1.936

Review 8.  Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment.

Authors:  Monika M Welle; Carla Rohrer Bley; Judith Howard; Silvia Rüfenacht
Journal:  Vet Dermatol       Date:  2008-12       Impact factor: 1.589

9.  Combination CCNU and vinblastine chemotherapy for canine mast cell tumours: 57 cases.

Authors:  Maureen Cooper; Xinru Tsai; Peter Bennett
Journal:  Vet Comp Oncol       Date:  2009-09       Impact factor: 2.613

10.  Clinicopathological findings and results of bone marrow aspiration in dogs with cutaneous mast cell tumours: 157 cases (1999-2002).

Authors:  M M Endicott; S C Charney; J A McKnight; A S Loar; A M Barger; P J Bergman
Journal:  Vet Comp Oncol       Date:  2007-03       Impact factor: 2.613
View more
  1 in total

Review 1.  Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus Proposal.

Authors:  Michael Willmann; Vilma Yuzbasiyan-Gurkan; Laura Marconato; Mauro Dacasto; Emir Hadzijusufovic; Olivier Hermine; Irina Sadovnik; Susanne Gamperl; Mathias Schneeweiss-Gleixner; Karoline V Gleixner; Thomas Böhm; Barbara Peter; Gregor Eisenwort; Richard Moriggl; Zhixiong Li; Mohamad Jawhar; Karl Sotlar; Erika Jensen-Jarolim; Veronika Sexl; Hans-Peter Horny; Stephen J Galli; Michel Arock; David M Vail; Matti Kiupel; Peter Valent
Journal:  Front Vet Sci       Date:  2021-12-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.